International Clinical Trial: Study on the efficacy and safety of AP regimen in the chronotherapy of advanced non-small cell lung Cancer

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119631) titled 'Study on the efficacy and safety of AP regimen in the chronotherapy of advanced non-small cell lung Cancer' on March 2.

Study Type: Observational study

Study Design: Cross-sectional

Primary Sponsor: Guangdong Second Provincial General Hospital (Guangdong Provincial Emergency Hospital)

Condition: Advanced non-small cell lung cancer

Intervention: Morning group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-05

Target Sample Size: Morning group:60;Afternoon group:60;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj...